In Q1 2024, RTW Investments held 55 positions worth $6.0B. They initiated 10 new positions and exited 23. Their largest holding was RCKT ($476.6M). Portfolio value grew +8.7% versus the prior quarter.
Frequently asked questions
What stocks did RTW Investments own in Q1 2024?
RTW Investments held 55 biotech stocks in their 13F portfolio in Q1 2024. Their top positions include RCKT, IMCR, AXSM, RARE, BRKRP. The full holdings table is available on BiotechEdge with position sizes, quarter-over-quarter changes, and AI analysis.
How much was RTW Investments's portfolio worth in Q1 2024?
RTW Investments's tracked biotech portfolio was worth $6.0B across 55 positions, with total assets under management of approximately $10B. Portfolio values are based on 13F filings with the SEC.
What did RTW Investments buy in Q1 2024?
RTW Investments initiated 10 new positions in Q1 2024, including DYN, KYTX, NGNE, JANX, LENZ and 5 more. They also increased 23 existing positions.
What did RTW Investments sell in Q1 2024?
RTW Investments fully exited 23 positions in Q1 2024, including VKTX, RLMD, PMVP, OLK, MLTX and 18 more. They also trimmed 5 existing positions.
Is RTW Investments a biotech fund?
Data-driven biotech fund led by a physician-investor who combines clinical expertise with quantitative analysis. RTW takes concentrated positions across the biotech lifecycle, from crossover privates to public equities, with a focus on therapeutic areas where clinical data can be independently modeled.
Want AI analysis, insider signals, and catalyst overlays for RTW Investments?
View latest RTW Investments portfolio →